These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9547349)
1. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Gajate C; Santos-Beneit A; Modolell M; Mollinedo F Mol Pharmacol; 1998 Apr; 53(4):602-12. PubMed ID: 9547349 [TBL] [Abstract][Full Text] [Related]
2. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Mollinedo F; Gajate C; Modolell M Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):325-9. PubMed ID: 8092982 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system. Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487 [TBL] [Abstract][Full Text] [Related]
4. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M Cancer Res; 1999 May; 59(10):2457-63. PubMed ID: 10344758 [TBL] [Abstract][Full Text] [Related]
5. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220 [TBL] [Abstract][Full Text] [Related]
6. Involvement of mitochondria and caspase-3 in ET-18-OCH(3)-induced apoptosis of human leukemic cells. Gajate C; Santos-Beneit AM; Macho A; Lazaro Md; Hernandez-De Rojas A; Modolell M; Muñoz E; Mollinedo F Int J Cancer; 2000 Apr; 86(2):208-18. PubMed ID: 10738248 [TBL] [Abstract][Full Text] [Related]
7. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines. Civoli F; Daniel LW Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778 [TBL] [Abstract][Full Text] [Related]
8. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518 [TBL] [Abstract][Full Text] [Related]
9. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy. Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170 [TBL] [Abstract][Full Text] [Related]
10. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis. Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines. Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410 [TBL] [Abstract][Full Text] [Related]
12. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway. Matsuda S; Minowa A; Suzuki S; Koyasu S J Immunol; 1999 Mar; 162(6):3321-6. PubMed ID: 10092785 [TBL] [Abstract][Full Text] [Related]
13. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Small GW; Strum JC; Daniel LW Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959 [TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines. Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054 [TBL] [Abstract][Full Text] [Related]
15. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. Mollinedo F; Martínez-Dalmau R; Modolell M Biochem Biophys Res Commun; 1993 Apr; 192(2):603-9. PubMed ID: 8484770 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Heesbeen EC; Verdonck LF; Staal GE; Rijksen G Biochem Pharmacol; 1994 Apr; 47(9):1481-8. PubMed ID: 8185658 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues. Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723 [TBL] [Abstract][Full Text] [Related]
18. Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes. Vrablic AS; Albright CD; Craciunescu CN; Salganik RI; Zeisel SH FASEB J; 2001 Aug; 15(10):1739-44. PubMed ID: 11481221 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation. Whitman SP; Civoli F; Daniel LW J Biol Chem; 1997 Sep; 272(38):23481-4. PubMed ID: 9295281 [TBL] [Abstract][Full Text] [Related]
20. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]